Investigative Ophthalmology & Visual Science Cover Image for Volume 63, Issue 7
June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Comparison Between Swept-Source and Spectral-Domain Optical Coherence Tomography Angiography in Ocular Hypertension and Glaucoma
Author Affiliations & Notes
  • Katherine Lun
    National University Hospital, Singapore, Singapore, Singapore
  • Bingyao Tan
    School of Chemical and Biochemical Engineering, Nanyang Technological University, Singapore, Singapore, Singapore
  • Chelvin Sng
    National University Hospital, Singapore, Singapore, Singapore
  • Leopold Schmetterer
    Singapore Eye Research Institute, Singapore, Singapore
  • Jacqueline Chua
    Singapore Eye Research Institute, Singapore, Singapore
  • Footnotes
    Commercial Relationships   Katherine Lun None; Bingyao Tan None; Chelvin Sng None; Leopold Schmetterer None; Jacqueline Chua None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 3499. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Katherine Lun, Bingyao Tan, Chelvin Sng, Leopold Schmetterer, Jacqueline Chua; Comparison Between Swept-Source and Spectral-Domain Optical Coherence Tomography Angiography in Ocular Hypertension and Glaucoma. Invest. Ophthalmol. Vis. Sci. 2022;63(7):3499.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : We compared the macular choriocapillaris flow deficit density (FDD) using swept-source (SS) and spectral-domain (SD) optical coherence tomography angiography (OCTA) in healthy participants (normal controls; n=104), individuals having ocular hypertension (OHT; n=41), and primary open-angle glaucoma (POAG; n=112).

Methods : In this prospective cross-sectional study, subjects underwent 3x3 mm2 imaging using both SS-OCTA (Plex Elite 9000) and SD-OCTA (Cirrus AngioPlex). Choriocapillaris OCTA images were extracted from the respective devices’ built-in review software and were subsequently loaded into a customized algorithm that evaluted the choriocapillaris FDD.

Results : When using SS-OCTA, older age was independently associated with higher choriocapillaris FDD (all P ≤ 0.026), after adjusting for confounders. Specifically, the oldest group (70-82 years old) had 1.11% (95% CI = 0.50 to 1.72; P < 0.001) more choriocapillaris FDD compared to the youngest group (24-44 years old). In addition, OHT patients had 0.86% (95% CI = 0.10 to 1.62; P = 0.026) more choriocapillaris FDD than normal controls, while it did not reach statistical significance for POAG (β = -0.78, 95% CI = -1.65 to 0.062; P = 0.08). In eyes imaged with SD-OCTA, choriocapillaris FDD was not associated with either age or eye disease.

Conclusions : Imaging with SS-OCTA showed higher choriocapillaris FDD in older patients and patients with OHT when compared with normal subjects, and this was not seen when imaged with SD-OCTA.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

 

Figure 1. Representative OCTA 3 × 3 mm2 images of normal controls who underwent Plex Elite (A to F) andAngioPlex (G to L) imaging and their corresponding color- coded maps (B, D, F, H, J, and L).

Figure 1. Representative OCTA 3 × 3 mm2 images of normal controls who underwent Plex Elite (A to F) andAngioPlex (G to L) imaging and their corresponding color- coded maps (B, D, F, H, J, and L).

 

Figure 2. Relationship between the choriocapillaris flow deficit density (%) when using the Plex Elite in normal control, OHT and POAG patients, stratified by age groups.

Figure 2. Relationship between the choriocapillaris flow deficit density (%) when using the Plex Elite in normal control, OHT and POAG patients, stratified by age groups.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×